AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Learn which retirement index funds are the cheapest and what factors influence cost, turnover, and suitability.
14,282 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
A landmark housing bill cleared Congress this week, promising to ease rents and expand homebuilding. President Trump ...
The quantum funding wave from Washington exposes a stark split: IonQ’s rapid revenue growth against IBM’s cash machin...
Cape Verde's Vozinha has surged to a $17 million valuation as World Cup spotlight boosts a small nation’s brand. Inve...
U.S. regulators have cleared broader access to Anthropic’s Mythos model after a brief regulatory stand-off over safet...
Caregiving and end-of-life decisions test both hearts and wallets. This article explores practical, compassionate ste...
Bitcoin faces renewed selling pressure this week, with analysts signaling a bitcoin (btc) price warning that a deeper...
Strong cloud demand and AI-driven spending helped lift amazon and alphabet today, putting the spotlight on the broade...
In 2026, Sharplink makes its first Ethereum purchase, signaling a calculated pivot in treasury strategy. This article...
When a loved one appears on a jail roster, scam artists step in with urgent payment requests. Learn how to spot these...
Voters in California face a pivotal choice on a billionaire wealth tax and new limits on local transfer taxes as hous...
MicroStrategy announces a sweeping Digital Credit Capital Framework that reshapes how it funds Bitcoin purchases and ...